Prescription Drugs Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 – 2030

CHAPTER 1. Industry Overview of Prescription Drugs Market

1.1. Definition and Scope

1.1.1. Definition of Prescription Drugs

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Prescription Drugs Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Prescription Drugs Market By Product Type

1.2.3. Prescription Drugs Market By Therapy

1.2.4. Prescription Drugs Market By Distribution Channel

1.2.5. Prescription Drugs Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Prescription Drugs Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Prescription Drugs Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Prescription Drugs Market By Product Type

4.1. Introduction

4.2. Prescription Drugs Revenue By Product Type

4.2.1. Prescription Drugs Revenue (USD Billion) and Forecast, By Product Type, 2018-2030

4.2.2. Generics

4.2.2.1. Generics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3. Orphan

4.2.3.1. Orphan Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4. Others Prescription Drugs

4.2.4.1. Others Prescription Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 5. Prescription Drugs Market By Therapy

5.1. Introduction

5.2. Prescription Drugs Revenue By Product Type

5.2.1. Prescription Drugs Revenue (USD Billion) and Forecast, By Product Type, 2018-2030

5.2.2. Oncology

5.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Anti-Diabetics

5.2.3.1. Anti-Diabetics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Vaccines

5.2.4.1. Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Sensory Organs

5.2.5.1. Sensory Organs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.6. Immunosuppressant’s

5.2.6.1. Immunosuppressant’s Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.7. Anticoagulants

5.2.7.1. Anticoagulants Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.8. Others

5.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Prescription Drugs Market By Distribution Channel

6.1. Introduction

6.2. Prescription Drugs Revenue By Distribution Channel

6.2.1. Prescription Drugs Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030

6.2.2. Hospital Pharmacies

6.2.2.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Retail Pharmacies & Drug Stores

6.2.3.1. Retail Pharmacies & Drug Stores Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Online Pharmacies

6.2.4.1. Online Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Prescription Drugs Market By Country 

7.1. North America Prescription Drugs Market Overview

7.2. U.S.

7.2.1. U.S. Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

7.2.2. U.S. Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

7.2.3. U.S. Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

7.3. Canada

7.3.1. Canada Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

7.3.2. Canada Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

7.3.3. Canada Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Prescription Drugs Market By Country

8.1. Europe Prescription Drugs Market Overview

8.2. U.K.

8.2.1. U.K. Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

8.2.2. U.K. Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

8.2.3. U.K. Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.3. Germany

8.3.1. Germany Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

8.3.2. Germany Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

8.3.3. Germany Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.4. France

8.4.1. France Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

8.4.2. France Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

8.4.3. France Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.5. Spain

8.5.1. Spain Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

8.5.2. Spain Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

8.5.3. Spain Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

8.6.2. Rest of Europe Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

8.6.3. Rest of Europe Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Prescription Drugs Market By Country

9.1. Asia Pacific Prescription Drugs Market Overview

9.2. China

9.2.1. China Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

9.2.2. China Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

9.2.3. China Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.3. Japan

9.3.1. Japan Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

9.3.2. Japan Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

9.3.3. Japan Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.4. India

9.4.1. India Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

9.4.2. India Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

9.4.3. India Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.5. Australia

9.5.1. Australia Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

9.5.2. Australia Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

9.5.3. Australia Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.6. South Korea

9.6.1. South Korea Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

9.6.2. South Korea Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

9.6.3. South Korea Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

9.7.2. Rest of Asia-Pacific Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

9.7.3. Rest of Asia-Pacific Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Prescription Drugs Market By Country

10.1. Latin America Prescription Drugs Market Overview

10.2. Brazil

10.2.1. Brazil Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

10.2.2. Brazil Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

10.2.3. Brazil Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.3. Mexico

10.3.1. Mexico Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

10.3.2. Mexico Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

10.3.3. Mexico Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

10.4.2. Rest of Latin America Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

10.4.3. Rest of Latin America Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Prescription Drugs Market By Country 

11.1. Middle East & Africa Prescription Drugs Market Overview

11.2. GCC

11.2.1. GCC Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.2.2. GCC Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

11.2.3. GCC Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.3. South Africa

11.3.1. South Africa Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.3.2. South Africa Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

11.3.3. South Africa Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.4.2. Rest of Middle East & Africa Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030

11.4.3. Rest of Middle East & Africa Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Prescription Drugs Market

12.1. Prescription Drugs Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Prescription Drugs Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Novartis AG

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Billion), 2021

13.1.3.2. Novartis AG 2021 Prescription Drugs Business Regional Distribution

13.1.4. Product /Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Pfizer Inc.

13.3. F.Hoffmann-La Roche Ltd

13.4. Sanofi

13.5. Johnson & Johnson Services, Inc.

13.6. Merck & Co., Inc.

13.7. Abbvie, Inc.

13.8. AstraZeneca